Koichi Seta

Fushimi, 6128555, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Glucocorticoid dose at discharge and the risk of infectious complications and rehospitalization in renal diseases.

Glucocorticoid dose at discharge and the risk of infectious complications and rehospitalization in renal diseases.

Journal: Clinical and experimental nephrology
Published: October 06, 2025

Radiation Nephropathy Complicated by Tubulointerstitial Nephritis with Predominantly Lymphocyte and Plasma Cell Infiltration.

Radiation Nephropathy Complicated by Tubulointerstitial Nephritis with Predominantly Lymphocyte and Plasma Cell Infiltration.

Journal: Internal medicine (Tokyo, Japan)
Published: November 04, 2024

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5.

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5.

Journal: Kidney international reports
Published: October 26, 2024

Membranoproliferative Glomerulonephritis with Striated Ultrastructural Deposits with Significantly Elevated Fibrinogen and Fibronectin on Mass Spectrometry Analysis: A Case Report and Literature Review.

Membranoproliferative Glomerulonephritis with Striated Ultrastructural Deposits with Significantly Elevated Fibrinogen and Fibronectin on Mass Spectrometry Analysis: A Case Report and Literature Review.

Journal: Nephron
Published: June 16, 2024

Prospective randomized trial of antibiotic prophylaxis for percutaneous renal biopsy.

Prospective randomized trial of antibiotic prophylaxis for percutaneous renal biopsy.

Journal: Clinical and experimental nephrology
Published: April 13, 2024

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).

Journal: Clinical and experimental nephrology
Published: February 19, 2024

Nafamostat Mesylate for the Hypercoagulable State of SARS-CoV-2 With Renal Replacement Therapy: A Case Report.

Nafamostat Mesylate for the Hypercoagulable State of SARS-CoV-2 With Renal Replacement Therapy: A Case Report.

Journal: Cureus
Published: January 17, 2024

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

Journal: Clinical and experimental nephrology
Published: November 04, 2023

Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

Journal: Clinical and experimental nephrology
Published: April 28, 2023

Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years.

Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years.

Journal: Aging and health research
Published: December 23, 2022

Peritoneal dialysis-related peritonitis caused by Rhodococcus corynebacterioides.

Peritoneal dialysis-related peritonitis caused by Rhodococcus corynebacterioides.

Journal: CEN case reports
Published: March 10, 2022

Antibiotic prophylaxis for percutaneous renal biopsy: study protocol for a prospective randomized trial.

Antibiotic prophylaxis for percutaneous renal biopsy: study protocol for a prospective randomized trial.

Journal: Trials
Published: January 09, 2022
Showing 1-12 of 26

Last Updated: 09/26/2026